SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-24-000003
Filing Date
2024-01-17
Accepted
2024-01-17 08:10:41
Documents
12
Period of Report
2024-01-17
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K halo-20240117.htm   iXBRL 8-K 62377
  Complete submission text file 0001159036-24-000003.txt   193425

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20240117.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20240117_lab.xml EX-101.LAB 24139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20240117_pre.xml EX-101.PRE 12522
6 EXTRACTED XBRL INSTANCE DOCUMENT halo-20240117_htm.xml XML 2712
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 24536767
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)